Proposed circadian-based three-tier framework for atrophic gastritis
This review proposes a three-tier circadian-based framework for managing chronic atrophic gastritis, a precancerous stage of gastric cancer; it is a proposal, not a tested intervention. [1]
Automatic summary · not editorially reviewed
The key findings
The review states that circadian rhythm disruption disturbs core clock genes including CLOCK, BMAL1, PER and CRY. [1]
According to the review, these alterations contribute to a pathological cascade that accelerates progression from chronic atrophic gastritis to gastric cancer. [1]
The review proposes a three-tier predictive, preventive and personalised medicine framework based on circadian-based individualised protection. [1]
The source at a glance
- Study type / format
- Review proposing a management framework (abstract only)
- Population / context
- People with chronic atrophic gastritis, described as a precancerous stage of gastric cancer.
- Summary based on
- Study abstract
- Original publication
- August 21, 2026
Circadian disruption and gastritis-to-cancer cascade
The review describes chronic atrophic gastritis as a critical precancerous stage in gastric cancer development. It states that disruption of circadian rhythm disturbs core clock genes, including CLOCK, BMAL1, PER and CRY. According to the review, these changes contribute to a multi-layered pathological cascade that accelerates progression from atrophic gastritis to gastric cancer. The review notes that existing studies have mostly treated circadian rhythm as a passive risk factor rather than an actionable target.
Supporting source [1]
Proposed predictive, prevention and treatment tiers
Building on a synthesis of mechanistic evidence, the review proposes a predictive, preventive and personalised medicine (PPPM/3PM) three-tier management framework based on circadian-based individualised protection. At the predictive level, digital biomarkers such as sleep-wake rhythms, light exposure, physical activity and dietary behaviour, multi-omics profiles and circadian-related molecular signatures are to be integrated for dynamic risk stratification of atrophic gastritis populations. At the targeted prevention level, pharmacological agents and natural compounds with circadian-regulating potential are to be used for proactive protective strategies tailored to pathological stages and circadian phenotypes. At the personalised treatment level, lifestyle interventions, chronotherapy, nano-carrier-based circadian-synchronised delivery and dynamic biomarker monitoring are to be combined into precision regimens informed by individual circadian phenotypes.
Supporting source [1]
Repositioning circadian rhythm as a target axis
The review states that its framework repositions circadian rhythm from a latent risk factor to a protectable and therapeutically targetable axis. It presents this as offering new insights into time-optimised intervention strategies for the inflammation-to-cancer transition in chronic atrophic gastritis. The abstract does not report a clinical trial, patient outcomes or validation of the framework; it is a proposal derived from a synthesis of mechanistic evidence.
Supporting source [1]
How to interpret this
This is an abstract only; the full text was not reviewed. The abstract describes a proposed framework built on a synthesis of mechanistic evidence and reports no clinical trial, patient outcomes or validation. Associations and mechanisms described do not establish that the proposed interventions prevent or treat gastric cancer.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Shan C, Guo M, Feng F, Wang X, Li M, Xu W, Jia K, Liu Y, Jia Y. · europepmc.org · August 21, 2026